Mercy Gilbert Medical Center
Welcome,         Profile    Billing    Logout  
 3 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nseir, Georges
RESTOR-1, NCT04663867: AngioSafe Peripheral CTO Crossing System Study ( Study)

Recruiting
N/A
100
US
AngioSafe Peripheral CTO Crossing System
AngioSafe, Inc., Veranex, Inc.
Peripheral Artery Occlusion, Peripheral Arterial Disease
02/23
02/23
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial

Active, not recruiting
N/A
2005
US
Orbital Atherectomy, Balloon
Abbott Medical Devices, Cardiovascular Research Foundation, New York
Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction
06/24
06/25
Mutoff, Brian
NCT05654922: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Recruiting
3
100
US
ARINA-1, Standard of care only
Renovion, Inc.
Pre-Bronchiolitis Obliterans Syndrome
01/25
06/25
ALL IN LUNG, NCT06033196: Tocilizumab in Lung Transplantation

Recruiting
2
350
Canada, US
Tocilizumab, ACTEMRA, Placebo for Tocilizumab
National Institute of Allergy and Infectious Diseases (NIAID)
Lung Transplant
01/29
01/29
Vermillion, Jennifer
TARGET-IV_NA, NCT04562532: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Active, not recruiting
N/A
1720
Europe, Canada, US
Microport Firehawk stent, MicroPort Firehawk rapamycin target eluting stent, 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
Shanghai MicroPort Medical (Group) Co., Ltd.
Coronary Artery Disease
06/24
06/27
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Recruiting
N/A
300
Europe, US
Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication
Cardiac Dimensions, Inc.
Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases
12/26
12/30
NCT05169840: Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

Recruiting
N/A
2000
US
Genetic Risk Score for Coronary Artery Disease, Conventional Risk Score for Coronary Artery Disease
St. Joseph's Hospital and Medical Center, Phoenix, Chandler Regional Medical Center, Mercy Gilbert Medical Center
Coronary Artery Disease, Genetic Predisposition to Disease
06/24
06/24
Leon, Natalie
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial

Active, not recruiting
N/A
2005
US
Orbital Atherectomy, Balloon
Abbott Medical Devices, Cardiovascular Research Foundation, New York
Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction
06/24
06/25
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Recruiting
N/A
300
Europe, US
Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication
Cardiac Dimensions, Inc.
Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases
12/26
12/30
NCT05169840: Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

Recruiting
N/A
2000
US
Genetic Risk Score for Coronary Artery Disease, Conventional Risk Score for Coronary Artery Disease
St. Joseph's Hospital and Medical Center, Phoenix, Chandler Regional Medical Center, Mercy Gilbert Medical Center
Coronary Artery Disease, Genetic Predisposition to Disease
06/24
06/24

Download Options